密西西比州杰克逊市儿童严重急性呼吸综合征冠状病毒2大流行监测的便利抽样
CONVENIENCE SAMPLING FOR PANDEMIC SURVEILLANCE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 IN CHILDREN IN JACKSON, MISSISSIPPI.
作者信息
Inagaki Kengo, Penny Amanda, Gwyn Sarah, Malloch Lacy, Martin Lora, Hankins Emma, Ray Chuck, Byers Paul, Harrison Austin, Handali Sukwan, Martin Diana, Hobbs Charlotte V
机构信息
From the Department of Pediatrics.
Division of Infectious Diseases, Department of Pediatrics, University of Mississippi Medical Center.
出版信息
Pediatr Infect Dis J. 2024 Dec 3. doi: 10.1097/INF.0000000000004636.
Abstract
We assessed severe acute respiratory syndrome coronavirus 2 seroprevalence on residual blood samples for pediatric COVID-19 surveillance: 2263 samples were collected during routine outpatient visits (<18 years, April 2020-August 2021). Seroprevalence increased over time, coinciding with or preceding virus circulation in the community and with or preceding pediatric severe COVID-19 hospitalization peaks. Residual blood sample seroprevalence may be a useful surveillance tool in future outbreaks.
摘要
我们评估了用于儿童新型冠状病毒肺炎监测的残留血样中严重急性呼吸综合征冠状病毒2的血清流行率：在2020年4月至2021年8月的常规门诊就诊期间收集了2263份样本（年龄<18岁）。血清流行率随时间增加，与社区中的病毒传播同时或提前出现，并与儿童严重新型冠状病毒肺炎住院高峰同时或提前出现。残留血样血清流行率可能是未来疫情中的一种有用监测工具。
相似文献
1
CONVENIENCE SAMPLING FOR PANDEMIC SURVEILLANCE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 IN CHILDREN IN JACKSON, MISSISSIPPI.密西西比州杰克逊市儿童严重急性呼吸综合征冠状病毒2大流行监测的便利抽样
Pediatr Infect Dis J. 2024 Dec 3. doi: 10.1097/INF.0000000000004636.
2
Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.基于血清阳性率的感染率进行主动监测表明，2020 年 3 月至 2021 年 2 月，密西西比州需要住院治疗的儿科 SARS-CoV-2 存在种族差异。
Pediatr Infect Dis J. 2022 Sep 1;41(9):736-741. doi: 10.1097/INF.0000000000003593. Epub 2022 Jun 7.
3
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020-May 2021.2020年8月至2021年5月美国儿童严重急性呼吸综合征冠状病毒2血清流行率及报告的2019冠状病毒病病例
Open Forum Infect Dis. 2022 Jan 30;9(3):ofac044. doi: 10.1093/ofid/ofac044. eCollection 2022 Mar.
4
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.商业实验室剩余血清检测与社区调查估算的严重急性呼吸综合征冠状病毒 2 血清流行率比较。
Clin Infect Dis. 2021 Nov 2;73(9):e3120-e3123. doi: 10.1093/cid/ciaa1804.
5
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) IgG-antibody seroprevalence among quarantined population, during the first wave of COVID-19 pandemic, In North West Ethiopia (from 30 April to 30 May 2020).2020年4月30日至5月30日，埃塞俄比亚西北部第一波新冠疫情期间，隔离人群中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）IgG抗体血清阳性率。
SAGE Open Med. 2022 Feb 7;10:20503121221076931. doi: 10.1177/20503121221076931. eCollection 2022.
6
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.2020 年 3 月至 8 月在美国 10 个地点的严重急性呼吸综合征冠状病毒 2 型血清阳性率随时间的变化。
Clin Infect Dis. 2021 Nov 16;73(10):1831-1839. doi: 10.1093/cid/ciab185.
7
Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.无代表性的估计：早期严重急性呼吸综合征冠状病毒 2 血清流行率研究及前进道路。
J Infect Dis. 2020 Sep 1;222(7):1086-1089. doi: 10.1093/infdis/jiaa429.
8
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.利用美国献血者进行严重急性呼吸综合征冠状病毒 2 抗体的全国血清学监测：扩大国家献血者血清学监测计划的基础。
Clin Infect Dis. 2022 Mar 9;74(5):871-881. doi: 10.1093/cid/ciab537.
9
Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children's hospital during coronavirus disease 2019 (COVID-19) pandemic.美国一家学术儿童医院在 2019 年冠状病毒病（COVID-19）大流行期间，严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）血清阳性率的演变。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1647-1655. doi: 10.1017/ice.2021.487. Epub 2021 Dec 2.
10
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.利用血清流行率调查估计美国 SARS-CoV-2 感染、有症状感染、住院和死亡人数。
JAMA Netw Open. 2021 Jan 4;4(1):e2033706. doi: 10.1001/jamanetworkopen.2020.33706.
本文引用的文献
1
COVID-19: A Pediatric Update in Epidemiology, Management, Prevention, and Long-term Effects.新型冠状病毒肺炎：儿科流行病学、管理、预防及长期影响的最新进展
Pediatr Rev. 2023 May 1;44(5):243-254. doi: 10.1542/pir.2022-005686.
2
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation.儿童多系统炎症综合征的危险因素：病例对照研究。
Pediatr Infect Dis J. 2023 Jun 1;42(6):e190-e196. doi: 10.1097/INF.0000000000003900. Epub 2023 Mar 16.
3
Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases.用于忽视热带病和其他疾病综合血清学监测的多重微球检测法中 SARS-CoV-2 抗原的性能。
Am J Trop Med Hyg. 2022 Jun 27;107(2):260-267. doi: 10.4269/ajtmh.22-0078. Print 2022 Aug 17.
4
Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy.血清学作为评估传染病态势和指导公共卫生政策的工具。
Pathogens. 2022 Jun 27;11(7):732. doi: 10.3390/pathogens11070732.
5
Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.基于血清阳性率的感染率进行主动监测表明，2020 年 3 月至 2021 年 2 月，密西西比州需要住院治疗的儿科 SARS-CoV-2 存在种族差异。
Pediatr Infect Dis J. 2022 Sep 1;41(9):736-741. doi: 10.1097/INF.0000000000003593. Epub 2022 Jun 7.
6
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.2020年5月至9月密西西比州18岁以下人群中估计的严重急性呼吸综合征冠状病毒2血清流行率
MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):312-315. doi: 10.15585/mmwr.mm7009a4.
7
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.截至 2020 年 9 月美国估计的 SARS-CoV-2 血清流行率。
JAMA Intern Med. 2021 Apr 1;181(4):450-460. doi: 10.1001/jamainternmed.2020.7976.
8
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.2020年3月23日至5月12日美国10个地点针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体的血清流行率
JAMA Intern Med. 2020 Jul 21. doi: 10.1001/jamainternmed.2020.4130.
Zotero 插件